2003
DOI: 10.5483/bmbrep.2003.36.1.128
|View full text |Cite
|
Sign up to set email alerts
|

Roles of Matrix Metalloproteinases in Tumor Metastasis and Angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
191
0
12

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 265 publications
(206 citation statements)
references
References 70 publications
3
191
0
12
Order By: Relevance
“…Most metalloproteinases are regarded as key regulators of tumor cell invasiveness, because they possess proteolytic activities to destruct the ECM and alter the cell-cell attachments and cell-matrix attachments, which are integral to tumor cell migration (38). However, little is known about the involvement of ADAMTS members in cell invasion except for ADAMTS1 and ADAMTS5.…”
Section: Discussionmentioning
confidence: 99%
“…Most metalloproteinases are regarded as key regulators of tumor cell invasiveness, because they possess proteolytic activities to destruct the ECM and alter the cell-cell attachments and cell-matrix attachments, which are integral to tumor cell migration (38). However, little is known about the involvement of ADAMTS members in cell invasion except for ADAMTS1 and ADAMTS5.…”
Section: Discussionmentioning
confidence: 99%
“…Cell migration and invasion are coordinated active processes involving ECM degradation by proteases such as MMPs [19,20]. At baseline we studied the effects of S1P on MMP expression and activity.…”
Section: S1p Regulation Of Dov 13 Invasiveness Correlates With Mmp-2 mentioning
confidence: 99%
“…Plasmin directly degrades various ECM components as well as activating matrix metalloproteinases (MMP's), a family of zinc-dependent endopeptidases capable of degrading virtually all ECM components and correlated with cellular invasiveness [7,[18][19][20]. uPA activity is upregulated by LPA in DOV 13 cells [21]; however, the effect of S1P on uPA activity is unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Normally, they are expressed during embryonic stages and during processes of tissue remodeling, such as ovulation, endometrial cycling and wound healing (Nagase and Woessner, 1999;Brinckerhoff and Matrisian, 2002). MMPs are frequently overexpressed in a variety of human tumors (Edwards and Murphy, 1998;Egeblad and Werb, 2002) and are recognized as important players in many steps of the metastatic process (Freije et al, 2003;Yoon et al, 2003;DeClerck et al, 2004). In breast cancer, as well as in many other cancers, increased MMP expression and activation correlates with increased metastatic potential and poor prognosis (Ishigaki et al, 1999;Jones et al, 1999;Duffy et al, 2000).…”
Section: Introductionmentioning
confidence: 99%